JPRN-UMIN000011785招募中未知
Phase II randomized controlled trial of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter arterial chemoembolization of hepatocellular carcinoma - NHO-TGMC-2013-02 (HCC-Epirubicin &Miriplatin-P-II)
Takasaki General Medical Center, National Hospital Organization0 个研究点目标入组 60 人开始时间: 2013年9月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Drug allergy by miriplatin or epirubicin. 2) Extrahepatic metastasis. 3) Portal venous invasion in the major trunk or first order branch. 4) Remarkable arterio-portal or arterio-venous shunting. 5) Hepatic artery occlusion. 6) Biliary reconstruction. 7) Comorbid diseases *Cardiac failure *Renal failure *Active infection *Active gastrointestinal bleeding *Active associated cancers *Hepatic encephalopathy *Refractory ascites or pleural effusion 8) Fever (more than 38 degrees Celsius) 9) Allergy to contrast media 10) Pregnant or lactating 11) Other reasons not indicated to this study judged by doctors.
研究者
相似试验
已完成
不适用
A randomized phase II trial comparing epirubicin, cisplatin, and capecitabine versus the combination of epirubicin, cisplatin, and capecitabine with pravastatin in patients with irresectable or metastatic gastric carcinomaCancerISRCTN23062732Erasmus Medical Center, Department of Medical Oncology (Netherlands)43
进行中（未招募）
1 期
A Randomised Phase II trial of Epirubicin, Oxaliplatin and Capecitebine (EOX) versus Docetaxel and Oxaliplatin (EITax) in the treatment of Advanced Gastro-oesophageal cancer - The ELECT trial - ELECT trialAdvanced Gastro-oesophageal cancerMedDRA version: 9.1Level: LLTClassification code 10062878Term: Gastrooesophageal cancerEUCTR2006-003332-29-GBICORG, all-Ireland Cooperative Oncology Research Group140
进行中（未招募）
不适用
A Randomised Phase II trial of Epirubicin, Oxaliplatin and Capecitebine (EOX) versus Docetaxel and Oxaliplatin (EITax) in the treatment of Advanced Gastro-oesophageal cancer - The ELECT trial - ELECT trialAdvanced Gastro-oesophageal cancerMedDRA version: 9.1Level: LLTClassification code 10062878Term: Gastrooesophageal cancerEUCTR2006-003332-29-IEICORG, all-Ireland Cooperative Oncology Research Group140
已完成
2 期
Phase II trial of Epirubicin / Cyclophosphamide (EC) followed by Nab-paclitaxel as neoadjuvant chemotherapy for node positive breast cancerBreast CancerJPRN-UMIN000009853Dokkyo Medical University23
招募中
不适用
A randomized phase II trial comparing epirubicin, cisplatin, and capecitabine versus the combination of epirubicin, cisplatin, and capecitabine with pravastatin in patients with irresectable or metastatic gastric carcinoma.advanced irresectable or metastatic gastric carcinomaNL-OMON27982ot applicable43